NCT06250725 Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners
| NCT ID | NCT06250725 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Sleep Disturbance |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-08-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if a 6-week videoconference intervention to teach skills to improve sleep is practical, acceptable, and helpful to persons living with memory loss, cognitive impairment, and/or dementia and care partners, individually or together.
Eligibility Criteria
Inclusion Criteria for the PLwCI: * Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), or caregiver-reported probable or possible cognitive impairment or * Montreal Cognitive Assessment (MOCA) score between 12 and 24; * Had ≥1 sleep problem ≥3x/week on the Neuropsychiatric Inventory (NPI)-Nighttime Behavior Subscale; * Have an eligible caregiver; * Be able to participate in the intervention sessions Inclusion Criteria for Caregivers: * ≥18 years old, co-residing with persons living with cognitive impairment (PLwCI); * Regularly assist the care recipient with ≥1 of 7 basic activities of daily living or * ≥1 of 7 Instrumental Activities of Daily Living for the past 6 months; * Have difficulty falling asleep or difficulty staying asleep for the last three months or * Have a Pittsburgh Sleep Quality Index (PSQI) of 5 or greater Exclusion Criteria: * PLwCI: Moderate to severe cognitive impairment * Individuals who are not yet adults * Pregnant women * Prisoners * Individuals who are not able to clearly understand English.
Contact & Investigator
Glenna Brewster, PhD, RN, FNP
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT06250725 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sleep Disturbance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06250725 currently recruiting?
Yes, NCT06250725 is actively recruiting participants. Contact the research team at glenna.brewster@emory.edu for enrollment information.
Where is the NCT06250725 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT06250725 clinical trial?
NCT06250725 is sponsored by Emory University. The principal investigator is Glenna Brewster, PhD, RN, FNP at Emory University. The trial plans to enroll 80 participants.